J&J Washes Hands Of Purell As GOJO Eyes Consumer Segment Growth
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson sells the Purell Hand Sanitizer brand, marking a major consumer health product divestment as the firm seeks to rebound from a troubled year for its consumer business.
You may also be interested in...
Insight Acquires Monistat In Third Deal With McNeil For Women’s OTC Drugs
Insight Pharmaceutical expanded its women’s health care footprint with the acquisition of the Monistat North American portfolio from McNeil Consumer Healthcare.
Under Consent Decree, J&J Delays Full Return Of Recalled OTCs Until 2012
Johnson & Johnson pushes back to 2012 the target for returning its full slate of recalled OTC drugs to market as it adjusts to operating under a consent decree with FDA and the Department of Justice.
Under Consent Decree, J&J Delays Full Return Of Recalled OTCs Until 2012
Johnson & Johnson doubled the projected impact on its earnings from the remediation due to the slowdown in sales caused by lower production and additional investments required to remediate and modernize facilities.